Abstract Non-coding RNAs (ncRNAs), which occupy the vast majority of human transcripts
are known for their inability to encode proteins. NcRNAs consist of a diverse range of RNA …

Therapeutic effectiveness in breast cancer can be limited by the underlying mechanisms of
pathogenesis, including epithelial-mesenchymal transition (EMT), cancer stem cells (CSCs) …

The present review aimed to outline different types of RNAs in cancer diagnostics and
treatment, and to provide novel insights into their clinical applications. RNAs, including …

Colorectal cancer (CRC) is one of malignant afflictions burdening people worldwide, mainly
caused by shortages of effective medical intervention and poorly mechanistic understanding …

Altered metabolic patterns in tumor cells not only meet their own growth requirements but
also shape an immunosuppressive microenvironment through multiple mechanisms …

Although the first discovery of a non-coding RNA (ncRNA) dates back to 1958, only in recent
years has the complexity of the transcriptome started to be elucidated. However, its …

Long non-coding RNAs (lncRNAs) are frequently dysregulated in multiple malignancies,
demonstrating their potential oncogenic or tumor-suppressive roles in tumorigenesis …

Accumulating studies have suggested that long non-coding RNAs (lncRNAs) have drawn
more and more attention in rheumatoid arthritis (RA), which can function as competitive …

This review article explores the possibility of developing an integrated approach to the
management of the different needs of endometrial cancer (EC) patients seeking to become …

Protein aggregation is classically considered the main cause of neuronal death in
neurodegenerative diseases (NDDs). However, increasing evidence suggests that alteration …